US2022098554A1PendingUtilityA1

Perivascular stromal cells from primate pluripotent stem cells

55
Assignee: RECYTE THERAPEUTICS INCPriority: Feb 18, 2014Filed: Jun 29, 2021Published: Mar 31, 2022
Est. expiryFeb 18, 2034(~7.6 yrs left)· nominal 20-yr term from priority
C12N 2506/02C12N 2501/15C12N 5/069C12N 5/0662C12N 2501/155C12N 2501/165C12N 2501/115C12N 2502/28C12N 5/0652
55
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention provides methods, compositions and kits for making and using pericyte-like cells or perivascular stromal cells derived from pPS cells.

Claims

exact text as granted — not AI-modified
1 .- 12 . (canceled) 
     
     
         13 . A method for differentiating pluripotent stem cells into pericyte-like cells, the method comprising: 1) obtaining embryoid bodies from pluripotent stem cells; 2) seeding embryoid bodies at high density in low attachment plates; 3) culturing the embryoid bodies in suspension in the presence of appropriate factors; and 4) dissociating the embryoid bodies and transferring the dissociated cells to adherent plates for further culturing in the presence of appropriate factors. 
     
     
         14 . The method of  claim 13 , wherein the seeding density of step 2) is at least 1.5×10 6  cells/mL. 
     
     
         15 . The method of  claim 13 , wherein the seeding density of step 2) is at least 3×10 6  cells/mL. 
     
     
         16 . The method of  claim 13 , wherein the cells are cultured in the presence of a BMP. 
     
     
         17 . The method of  claim 16 , wherein the BMP is BMP-4. 
     
     
         18 . The method of  claim 13 , wherein further culturing of step 4 is performed in a medium comprising bFGF, optionally also comprising VEGF-A, optionally also comprising a TGFβ signaling inhibitor. 
     
     
         19 . The method of  claim 13 , further comprising an additional step of dissociating and harvesting of cells of step 4, and expanding said cells by further culturing on adherent plates in the presence of appropriate factors. 
     
     
         20 . The method of  claim 19 , wherein the additional step is performed in a medium not comprising BMP.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.